GO:0009374 biotin binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0009374 biotin binding is a molecular function defined as binding to biotin, the (+) enantiomer of which is widely distributed in cells and serves as a carrier in enzymatic beta-carboxylation reactions.
Biotin-binding proteins such as streptavidin, avidin, and biotin-dependent enzymes exploit the high affinity and specificity of biotin recognition for diverse biological and biotechnological applications [1,3].
The interaction between biotin and proteins is driven by a deep binding pocket that recognizes the ureido ring and tetrahydrothiophene moiety, with sulfur substitution affecting affinity [2,3].
Engineered biotin-binding proteins, including streptavidin monomers and Twin-Strep-tag, enable protein labeling, purification, and monovalent biotin detection [4,7].
Competitive binding assays using avidin and biotin-4-fluorescein provide quantitative tools to study biotin and biotin derivatives [6,8].
Biotin-binding Fv antibodies screened from autodisplayed libraries offer alternative recognition elements for biotin detection and diagnostics.

Description

Biotin binding (GO:0009374) is a molecular function that describes the specific interaction between a protein or other molecule and biotin, also known as vitamin B7 or vitamin H. Biotin is a water-soluble vitamin that serves as a covalently bound cofactor in a number of enzymatic beta-carboxylation reactions, where it carries activated carboxyl groups. The (+) enantiomer of biotin is the biologically active form widely distributed in cells. This binding function is fundamental to both natural biotin-dependent enzymes and engineered biotin-binding proteins used in biotechnology. Researchers study biotin binding to understand metabolic carboxylation, to develop affinity reagents for detection and purification, and to engineer proteins with tailored binding properties [1,3]. The high affinity and specificity of proteins such as streptavidin and avidin for biotin have made this interaction a cornerstone of molecular biology [1,4]. Recent work has explored how modifications, such as sulfur substitution, influence binding affinity, providing insights into the molecular determinants of recognition. Additionally, novel biotin-binding antibodies and competitive assays continue to expand the toolkit for biotin detection and quantification [5,6].

biotin binding At A Glance

GO ID GO:0009374
GO term biotin binding
Ontology molecular_function
Synonym vitamin B7 binding, vitamin H binding
Definition Binding to biotin (cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid), the (+) enantiomer of which is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions.
Major function Specific recognition and non-covalent interaction with biotin, enabling its use as a cofactor carrier or as a target for affinity reagents.
Related proteins Streptavidin, avidin, biotin-dependent carboxylases, engineered biotin-binding antibodies and tags.
Applications Protein purification, labeling, detection, competitive assays, and structural studies of protein-ligand interactions.

What Is GO:0009374?

In the Gene Ontology, biotin binding (GO:0009374) is defined as the binding to biotin (cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid), the (+) enantiomer of which is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions. This molecular function encompasses the selective and non-covalent interaction between a binding partner (typically a protein) and the biotin molecule. It is a molecular function term, meaning it describes an activity rather than a biological process or cellular component. The definition highlights the chemical nature of biotin and its role as a carrier of carboxyl groups in enzymatic reactions.

Why Is biotin binding Important in Cell Biology?

Biotin binding is critically important because biotin serves as an essential cofactor for carboxylase enzymes involved in fatty acid synthesis, gluconeogenesis, and amino acid metabolism. The high-affinity interaction between biotin and proteins like streptavidin and avidin underpins countless biotechnological applications, including affinity purification, immunoassays, and molecular imaging [1,4]. Understanding the structural basis of biotin recognition informs the design of improved affinity reagents and inhibitors [2,3]. Moreover, biotin-binding proteins are used in diagnostics and therapeutics, and alterations in biotin metabolism can have clinical implications [6,8].
Biotin is an essential cofactor for carboxylase enzymes in fatty acid synthesis, gluconeogenesis, and amino acid catabolism.
The streptavidin-biotin interaction is one of the strongest non-covalent interactions known, widely used in biotechnology [1,4].
Biotin-binding proteins enable sensitive detection and quantification of biotin and biotinylated molecules in research and diagnostics [6,8].
Engineered streptavidin monomers allow monovalent biotin detection and site-specific protein labeling.
Twin-Strep-tag, a engineered streptavidin-binding peptide, facilitates gentle purification of recombinant proteins.
Biotin-binding Fv antibodies provide alternative recognition elements for biotin in diagnostic assays.
Sulfur substitution in biotin analogs modulates binding affinity, offering insights into molecular recognition.
Competitive binding assays using avidin and biotin-4-fluorescein are robust methods for studying biotin derivatives.
Structural studies of protein-biotin interactions reveal conserved binding motifs and guide protein engineering.
Biotin binding is relevant to inherited disorders of biotin metabolism and to the development of targeted therapies [1,8].

Molecular Mechanism of biotin binding

Biotin Recognition and Binding Pocket
In simple terms: Biotin fits into a specific pocket in proteins like a key in a lock.
Biotin-binding proteins typically possess a deep, preformed binding pocket that accommodates the ureido ring and tetrahydrothiophene moiety of biotin. The binding is stabilized by a network of hydrogen bonds and van der Waals interactions, with aromatic residues often contributing to the hydrophobic environment. The high specificity ensures that only biotin and close analogs are recognized, which is critical for biological function and biotechnological applications [1,3].
Structural Determinants of Affinity
In simple terms: Small changes in the protein or biotin can alter how tightly they stick together.
The affinity of biotin binding can be modulated by structural variations. For example, sulfur substitution in the biotin molecule affects binding affinity to streptavidin, as demonstrated by Groaz et al. (2024). Such studies reveal that the tetrahydrothiophene ring and its sulfur atom contribute significantly to the overall binding energy. Understanding these determinants aids in the design of biotin analogs with tailored properties.
Biotin as a Cofactor Carrier
In simple terms: Biotin acts like a shuttle that carries chemical groups between enzymes.
In enzymatic beta-carboxylation reactions, biotin is covalently attached to a conserved lysine residue of carboxylase enzymes. The biotin moiety then swings between active sites to transfer activated carboxyl groups. This function relies on the specific binding of biotin within the enzyme's biotin carboxylase and carboxyltransferase domains. The binding is essential for the catalytic cycle of these enzymes.
Engineered Biotin-Binding Proteins
In simple terms: Scientists have modified natural biotin binders to create better tools.
Engineered variants of streptavidin, such as stable monomers, have been developed for monovalent biotin detection and protein labeling. The Twin-Strep-tag, a peptide that binds to streptavidin, enables efficient protein purification. Additionally, biotin-binding Fv antibodies have been screened from libraries for use in diagnostics. These engineered proteins expand the utility of biotin binding in research and medicine [4,5,7].
Assays for Biotin Binding
In simple terms: Special tests can measure how well proteins bind to biotin.
Competitive binding assays using avidin and biotin-4-fluorescein allow quantification of biotin and its derivatives. White (1997) described competitive binding assays for biotin-binding proteins, providing methods to assess binding affinity and specificity. These assays are valuable for characterizing engineered proteins and for detecting biotin in biological samples [6,8].

Key Genes Involved in GO:0009374 biotin binding

The following genes and proteins are key players in biotin binding, encompassing natural biotin-dependent enzymes, bacterial streptavidin, egg-white avidin, and engineered variants used in research.
GeneMajor RoleResearch Relevance
HLCSHolocarboxylase synthetase, catalyzes biotin attachment to carboxylasesDefects cause holocarboxylase synthetase deficiency; target for studying biotin metabolism
BTDBiotinidase, recycles biotin from biocytinDeficiency leads to biotinidase deficiency; model for biotin recycling
PCPyruvate carboxylase, biotin-dependent enzyme in gluconeogenesisStudied for metabolic disorders and as a model for biotin binding
ACC1Acetyl-CoA carboxylase 1, biotin-dependent enzyme in fatty acid synthesisTarget for obesity and cancer research
ACC2Acetyl-CoA carboxylase 2, regulates fatty acid oxidationPotential target for metabolic diseases
MCCC1Methylcrotonoyl-CoA carboxylase subunit 1, biotin-dependentDefects cause 3-methylcrotonyl-CoA carboxylase deficiency
MCCC2Methylcrotonoyl-CoA carboxylase subunit 2, biotin-dependentStudied in organic acidemias
PCCAPropionyl-CoA carboxylase alpha subunit, biotin-dependentDefects cause propionic acidemia
PCCBPropionyl-CoA carboxylase beta subunit, biotin-dependentDefects cause propionic acidemia
SLC5A6Sodium-dependent multivitamin transporter, transports biotinInvolved in biotin uptake; target for biotin transport studies
SAV1Streptavidin from Streptomyces avidiniiWidely used in biotechnology for biotin binding [1,4]
AVDAvidin from chicken egg whiteModel for high-affinity biotin binding [1,3]
BBSBiotin-binding Fv antibodies (engineered)Alternative recognition elements for biotin detection
Twin-Strep-tagEngineered streptavidin-binding peptideUsed for protein purification
Biotin-4-fluoresceinFluorescent biotin derivativeUsed in competitive binding assays
Streptavidin monomerEngineered monovalent streptavidinEnables monovalent biotin detection and labeling
Biotin carboxylaseComponent of biotin-dependent carboxylasesCatalyzes ATP-dependent carboxylation of biotin
CarboxyltransferaseComponent of biotin-dependent carboxylasesTransfers carboxyl group from biotin to substrate

How Is biotin binding Regulated?

The expression and activity of biotin-binding proteins are regulated at multiple levels. In bacteria, streptavidin production is controlled by quorum sensing and nutrient availability. In humans, biotin homeostasis is regulated by biotin transporters and holocarboxylase synthetase, which attaches biotin to carboxylases. Biotinidase recycles biotin from degraded carboxylases, maintaining biotin pools. Additionally, the binding affinity of engineered biotin-binding proteins can be tuned by directed evolution and rational design [4,7].

biotin binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
BTDBiotinidase deficiencyKnockout cell model to study biotin recycling
HLCSHolocarboxylase synthetase deficiencyPoint mutation knock-in to mimic patient variants
PCPyruvate carboxylase deficiencyKnockout in hepatocytes to study gluconeogenesis
PCCAPropionic acidemiaKnock-in of patient mutations in cell lines
ACC1Cancer metabolismOverexpression in cancer cell lines to study lipogenesis
Biotin Metabolism Disorders
Inherited deficiencies in biotinidase (BTD) or holocarboxylase synthetase (HLCS) lead to multiple carboxylase deficiency, characterized by metabolic acidosis, neurological symptoms, and skin rash. These disorders highlight the importance of biotin binding in carboxylase function. Treatment with biotin supplementation can be effective, underscoring the role of biotin binding in therapy.
Cancer and Metabolic Reprogramming
Biotin-dependent carboxylases such as acetyl-CoA carboxylase (ACC) are often upregulated in cancer to support fatty acid synthesis. Targeting biotin binding in these enzymes is a potential therapeutic strategy. Additionally, streptavidin-biotin technology is used in cancer diagnostics and targeted therapies.
Diagnostic Applications
Biotin-binding proteins are used in immunoassays and diagnostic tests, where high-affinity binding enables sensitive detection [6,8]. Engineered biotin-binding antibodies and competitive assays improve the accuracy of biotin measurement in clinical samples [5,6].

From biotin binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of BTD affect biotin recycling?BTD knockout cell line
How do patient mutations in HLCS affect biotin binding?HLCS point mutation knock-in
Can engineered streptavidin improve detection?Streptavidin monomer overexpression
What is the role of ACC1 in cancer lipogenesis?ACC1 knockout in cancer cells
How does biotin transport affect metabolism?SLC5A6 knockout or overexpression
Can Twin-Strep-tag purify low-abundance proteins?Twin-Strep-tag knock-in cell line

How to Study the biotin binding Process

MethodWhat It MeasuresTypical Application
Competitive binding assayAffinity and specificity of biotin-binding proteinsCharacterization of engineered proteins
Isothermal titration calorimetryBinding affinity and thermodynamicsQuantifying biotin-protein interactions
X-ray crystallographyThree-dimensional structure of binding pocketStructural studies of biotin binding
Phage displaySelection of biotin-binding peptides or antibodiesEngineering novel binders
Surface plasmon resonanceReal-time binding kineticsMeasuring affinity of biotin analogs
Fluorescence polarizationBinding affinity in solutionHigh-throughput screening
Affinity purificationProtein purity and yieldPurification of recombinant proteins
Protein labelingSite-specific labeling efficiencyImaging and detection
Competitive Binding Assays
Competitive binding assays using avidin and biotin-4-fluorescein allow quantification of biotin and its derivatives. White (1997) described methods for assaying biotin-binding proteins, providing robust protocols for measuring affinity and specificity. These assays are essential for characterizing engineered biotin-binding proteins [6,8].
Structural Biology
X-ray crystallography and NMR spectroscopy have been used to determine the structures of biotin-binding proteins, revealing the molecular details of the binding pocket. Such studies inform the design of biotin analogs and engineered proteins [2,3].
Protein Engineering and Screening
Directed evolution and phage display are used to engineer biotin-binding proteins with altered affinity. Screening of Fv libraries displayed on E. coli outer membrane has yielded biotin-binding antibodies. These methods enable the development of novel reagents [4,5].
Affinity Purification and Labeling
Twin-Strep-tag and streptavidin monomers are used for affinity purification and site-specific labeling of proteins [4,7]. These techniques leverage the high affinity of biotin binding for gentle and efficient purification.

How CRISPR Can Be Used to Study GO:0009374 biotin binding

Knockout

CRISPR knockout of genes encoding biotin-binding proteins, such as BTD or HLCS, can create cell models to study biotin metabolism and carboxylase function. These models help elucidate the consequences of loss of biotin binding in disease.

Point Mutation

Introducing patient-specific point mutations in genes like HLCS or PC using CRISPR allows researchers to study how altered biotin binding affects enzyme activity and leads to disease phenotypes. Such models are valuable for testing therapeutic interventions.

Knock-in

Knock-in of tagged biotin-binding proteins, such as Twin-Strep-tag or fluorescent proteins, enables tracking and purification of the tagged protein. This approach is useful for studying localization and interactions of biotin-binding proteins.

Overexpression

Overexpression of biotin-binding proteins like streptavidin or ACC1 in cell lines can be achieved by CRISPR activation or lentiviral delivery [1,4]. Overexpression models are used to study the effects of increased biotin binding on cellular processes.

How EDITGENE Supports biotin binding Research

Researchers studying biotin binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models, enabling functional validation of genes associated with biotin binding and metabolism.
Contact EDITGENE today to design your custom CRISPR model for biotin binding research.

Frequently Asked Questions About biotin binding

Biotin binding (GO:0009374) is a molecular function defined as the binding to biotin, a vitamin that serves as a carrier in enzymatic beta-carboxylation reactions.
Genes involved include BTD, HLCS, PC, ACC1, ACC2, MCCC1, MCCC2, PCCA, PCCB, and SLC5A6, as well as bacterial streptavidin (SAV1) and chicken avidin (AVD).
The Gene Ontology term for biotin binding is GO:0009374, under the molecular_function ontology.
Biotin binding is studied using competitive binding assays, structural biology, protein engineering, and affinity purification techniques [3,6,8].
Deficiencies in biotinidase or holocarboxylase synthetase cause multiple carboxylase deficiency, and altered biotin binding in carboxylases is linked to metabolic disorders and cancer.
Streptavidin binds biotin with extremely high affinity, among the strongest non-covalent interactions known, making it invaluable in biotechnology [1,4].
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study genes involved in biotin binding and their roles in disease.
They are used for protein purification, labeling, detection, diagnostics, and as tools in structural biology [1,4,7].
Sulfur substitution in biotin can alter binding affinity to streptavidin, providing insights into molecular recognition.
Competitive binding assays use avidin and biotin-4-fluorescein to quantify biotin and its derivatives by measuring displacement [6,8].

Conclusion

Biotin binding (GO:0009374) is a fundamental molecular function with broad implications in metabolism, biotechnology, and disease. The high-affinity interaction between biotin and proteins like streptavidin and avidin has revolutionized research tools, while biotin-dependent carboxylases are essential for metabolic pathways. Understanding the structural and mechanistic details of biotin binding continues to drive innovations in protein engineering and diagnostics. EDITGENE's CRISPR services empower researchers to dissect the roles of biotin-binding genes in health and disease.

References

  1. 1. Bayer EA et al.. 1990. Biotin-binding proteins: overview and prospects.. Methods Enzymol 184:49-51 PMID: 2201883
  2. 2. Groaz E et al.. 2024. Impact of sulfur substitution on biotin binding affinity to streptavidin.. Bioorg Chem 150:107600 PMID: 38945086
  3. 3. Lindqvist Y et al.. 1996. Protein-biotin interactions.. Curr Opin Struct Biol 6(6):798-803 PMID: 8994880
  4. 4. Lim KH et al.. 2013. Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection.. Biotechnol Bioeng 110(1):57-67 PMID: 22806584
  5. 5. Lee SJ et al.. 2021. Screening of biotin-binding F(V)-antibodies from autodisplayed F(V)-library on E. coli outer membrane.. Anal Chim Acta 1169:338627 PMID: 34088371
  6. 6. Oberbichler E et al.. 2020. Competitive binding assay for biotin and biotin derivatives, based on avidin and biotin-4-fluorescein.. Methods Enzymol 633:1-20 PMID: 32046840
  7. 7. Schmidt TG et al.. 2013. Development of the Twin-Strep-tag® and its application for purification of recombinant proteins from cell culture supernatants.. Protein Expr Purif 92(1):54-61 PMID: 24012791
  8. 8. White HB 3rd. 1997. Competitive binding assays for biotin-binding proteins.. Methods Enzymol 279:464-6 PMID: 9211298
Contact Us
*
*
*
*
How did you hear about us: